Masimo Corporation
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000C3W281
MASI
Masimo Corporation
GICS: 35101010
·
Sector: Healthcare
·
Sub-Sector: Medical Instruments & Supplies
NAME
Masimo Corporation
ISIN
US5747951003
TICKER
MASI
MIC
XNAS
REUTERS
MASI.OQ
BLOOMBERG
MASI US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 05.11.2024
Masimo
US5747951003
Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter ended September 28, 2024.
Third Quarter 2024 Results
Consolidated revenue was $504.6 million, comprised of healthcare revenue of $343.3 million and non-healthcare revenue of $161.3 million. Shipments of noninvasive technology boards and instruments were...
Tue, 29.10.2024
Masimo
US5747951003
Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in Nashville, Tennessee, is piloting the use of the Masimo Radius VSM™ patient-worn vital signs monitor with Masimo Patient SafetyNet™ supplemental remote monitoring in the Emergency Department (ED) and nontraditional care spaces....
Tue, 22.10.2024
Masimo
US5747951003
Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Michelle Brennan, interim Chief Executive Officer, Micah Young, Executive Vi...
Fri, 18.10.2024
Masimo
US5747951003
Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company’s Board of Directors (the “Board”), effective immediately. Following these appointments, the Board will consist of eight directors.
Quentin Koffey, Lead Independent Director of Masimo, sta...
Wed, 25.09.2024
Masimo
US5747951003
Today the Board of Directors (the “Board”) of Masimo (Nasdaq: MASI) a leading global medical innovator, provided a series of leadership and business updates:
Leadership Appointments
Michelle Brennan, a current member of Masimo’s Board, has been appointed interim Chief Executive Officer (“CEO”) following Chairman and CEO Joe Kiani informing the B...
Thu, 19.09.2024
Masimo
US5747951003
Politan Capital Management (together with its affiliates, “Politan”), a 9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today commented on the outcome of the Company’s Annual Meeting of Stockholders (the “Annual Meeting”).
Both of Politan’s independent nominees – Darlene Solomon and William Jellison – were elected...
Tue, 17.09.2024
Masimo
US5747951003
Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today highlighted that leading proxy advisory firm Glass, Lewis & Co. (“Glass Lewis”) has updated its earlier report to reiterate its recommendation that shareholders vote FOR the election ...
Tue, 17.09.2024
Masimo
US5747951003
Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today issued an open letter to shareholders in advance of the Company’s 2024 Annual Meeting of Stockholders (the “Annual Meeting”), set for September 19.
This press release features multimedia....
Mon, 16.09.2024
Masimo
US5747951003
Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in this contest for control of the Masimo Board and urging stockholders to vote “FOR” only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, ...
Sun, 15.09.2024
Masimo
US5747951003
Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today issued the following statement:
“With its motion for a preliminary injunction denied, Masimo pivoted this Saturday to asking the California Federal Court to effectively invalidate Polita...
Information on product placements
